We thank the authors for their interest in our paper, and their queries. In response to Yue Li and Guangsen Liu, given the current situation of malaria deaths and cases increasing in recent years,1 it ...

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.